Pure Bioscience Inc. | Balance Sheet
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
32.00
86.00
1,396.00
5,269.00
1,715.00
926
Total Accounts Receivable
18.00
47.00
189.00
263.00
297.00
275
Inventories
365.00
249.00
207.00
350.00
273.00
197
Other Current Assets
71.00
96.00
187.00
260.00
174.00
58
Total Current Assets
486.00
478.00
1,979.00
6,142.00
2,459.00
1,456
Net Property, Plant & Equipment
146.00
36.00
90.00
440.00
548.00
461
Intangible Assets
1,430.00
1,345.00
1,192.00
980.00
822.00
658
Total Assets
2,062.00
1,859.00
3,261.00
7,562.00
3,829.00
2,575
ST Debt & Current Portion LT Debt
368.00
-
4.00
-
-
Accounts Payable
1,134.00
1,096.00
560.00
479.00
426.00
Other Current Liabilities
651.00
733.00
305.00
2,057.00
2,102.00
Total Current Liabilities
2,153.00
1,829.00
869.00
2,536.00
2,528.00
Long-Term Debt
887.00
-
-
-
-
Other Liabilities
13.00
13.00
9.00
3.00
11.00
Total Liabilities
3,053.00
1,842.00
878.00
2,539.00
2,539.00
Common Equity (Total)
991.00
17.00
2,383.00
5,023.00
1,290.00
Total Shareholders' Equity
991.00
17.00
2,383.00
5,023.00
1,290.00
Total Equity
991.00
17.00
2,383.00
5,023.00
1,290.00
Liabilities & Shareholders' Equity
2,062.00
1,859.00
3,261.00
7,562.00
3,829.00
About Pure Bioscience
View Profile
